Defining Proteoform-Specific Drug Interactions in Native Sig
2026-05-29
This study pioneers the direct analysis of proteoform-specific interactions between membrane proteins and small molecules within native lipid environments using advanced mass spectrometry. The findings reveal how post-translational modifications and alternative splicing shape drug binding, offering new avenues for precision pharmacology and therapeutic development.
In Vitro Susceptibility of Staphylococci to Mupirocin and No
2026-05-29
This study by Fulham et al. systematically assessed the in vitro susceptibility of meticillin-resistant and meticillin-susceptible staphylococci from dogs to mupirocin and novobiocin, using rigorous microbiological techniques. The findings highlight the continued efficacy of mupirocin against both MSS and MRS isolates, while revealing reduced susceptibility of MRS to novobiocin, underscoring the need for informed antimicrobial selection in veterinary dermatology.
Z-VAD-FMK in Apoptosis Research: Protocols and Innovations
2026-05-28
Unlock the full potential of Z-VAD-FMK in dissecting caspase-dependent cell death, with advanced workflow insights and troubleshooting strategies. This guide bridges recent mechanistic breakthroughs with hands-on laboratory protocols for reproducible, high-impact apoptosis inhibition studies.
Ciprofloxacin Hydrochloride: Next-Gen Insights for Translati
2026-05-28
This thought-leadership article, authored by APExBIO's Head of Scientific Marketing, delivers a nuanced exploration of ciprofloxacin hydrochloride as both a fluoroquinolone antibiotic and a translational tool. We synthesize mechanistic discoveries, single-cell antibiotic antagonism findings, and practical guidance for researchers seeking to optimize antibacterial, immunomodulatory, and stress-response models. Enhanced by scenario-driven best practices and cross-linked to leading protocols, this article stakes new ground beyond conventional product pages—equipping investigators to maximize the impact and reproducibility of their antimicrobial experiments.
Benzyl Quinolone Carboxylic Acid in M1 Receptor Assay Workfl
2026-05-27
Benzyl Quinolone Carboxylic Acid (BQCA) enables precise, reproducible potentiation of M1 muscarinic acetylcholine receptor signaling, accelerating research in cognitive enhancement and Alzheimer's disease. This guide translates reference-driven insights and real-world protocols into actionable experimental strategies, troubleshooting, and advanced applications for neuroscience labs.
Applied Workflows and Innovation with Cefazedone (Refosporen
2026-05-27
Cefazedone (Refosporen), available from APExBIO, empowers researchers with robust, β-lactamase-resistant activity for both in vitro and in vivo models of Gram-positive and Gram-negative infections. This article translates recent workflow enhancements, pharmacokinetic breakthroughs, and troubleshooting strategies into actionable protocols for antibacterial research and clinical translation.
Tyrothricin Peptide Antibiotic Mixture: Protocols & Troubles
2026-05-26
Tyrothricin, a robust peptide antibiotic mixture from APExBIO, delivers reproducible, broad-spectrum antimicrobial activity for advanced infection control assays. This guide covers optimized workflows, protocol refinements, and troubleshooting strategies, with direct translation of recent mechanistic findings and workflow insights.
Exome Sequencing Reveals UV and TSA Mutation Signatures in K
2026-05-26
This study leverages exome sequencing to comprehensively profile mutation signatures induced by UVB radiation and trichostatin A (TSA) in primary human keratinocytes. Key findings include the identification of novel UV-induced mutation motifs and the dual role of TSA as both a chromatin-modifying protector and a mutagen, offering new insights into mutagenesis and skin cancer risk.
Anti-Inflammatory, Antiangiogenic Airway Stent Suppresses TI
2026-05-25
Zhao et al. present a dual-action airway stent combining anti-inflammatory and antiangiogenic functionalities, demonstrating significant suppression of tracheal in-stent restenosis (TISR) in preclinical models. This innovation addresses the intertwined processes of inflammation, vascularization, and fibroblast activation, offering a new paradigm for stent-based interventions.
MK 0893: Glucagon Receptor Antagonist for Diabetes Research
2026-05-25
MK 0893 is a potent, reversible glucagon receptor antagonist that enables precise interrogation of GCGR signaling in both cellular and in vivo diabetes models. Its nanomolar potency and validated allosteric binding make it a benchmark tool for dissecting cAMP inhibition and glucose regulation, as shown in recent structure-activity relationship studies.
S-Adenosylhomocysteine: Precision Tools for Methylation Cycl
2026-05-24
S-Adenosylhomocysteine (SAH) from APExBIO empowers researchers to dissect methylation dynamics and metabolic feedback in disease models with unmatched clarity. This guide delivers experimental workflows, troubleshooting insights, and strategic protocol enhancements tailored for advanced methyltransferase inhibition and neurobiology applications.
Faropenem Sodium: Protocols and Innovations for Resistance S
2026-05-23
Faropenem sodium empowers robust in vitro and in vivo models for Gram-positive, Gram-negative, and anaerobic bacterial inhibition, thanks to its broad-spectrum activity and unique stability. This guide translates the latest research and reference breakthroughs into actionable laboratory protocols, advanced troubleshooting, and strategic applications for resistance and infection research.
Phosphatase Inhibitor Cocktail 1: Workflow-Driven Phosphoryl
2026-05-22
Phosphatase Inhibitor Cocktail 1 (100X in DMSO) empowers researchers to capture true phosphorylation states across complex workflows, from Western blotting to phosphoproteomics. Discover how this APExBIO solution streamlines signal fidelity and troubleshooting for high-impact experiments in cancer signaling and beyond.
Intra- and Extracellular Dicloxacillin Activity in MSSA Mode
2026-05-22
This article reviews a pivotal study investigating the intra- and extracellular antibacterial activity of dicloxacillin against methicillin-sensitive Staphylococcus aureus (MSSA) using both in vitro and in vivo models. The research provides evidence that dicloxacillin maintains potent activity against MSSA in both compartments, with pharmacokinetic/pharmacodynamic indices guiding optimal dosing strategies for experimental and translational applications.
In Vitro Susceptibility of Staphylococci to Mupirocin and No
2026-05-21
Fulham et al. investigated the in vitro activity of mupirocin and novobiocin against both meticillin-resistant and meticillin-susceptible staphylococci isolated from canine skin. Their findings highlight the continued efficacy of mupirocin and the variable activity of novobiocin against resistant strains, informing antimicrobial stewardship and experimental design in both veterinary and comparative infection research.
460 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page